Diabetes mellitus and hepatocellular carcinoma: Comparison of Chinese patients with and without HBV-related cirrhosis

Table 1 Demographic, clinical, laboratory, metabolic and instrumental features of 224 hepatocellular carcinoma patients n (%)

Variable	HCC patients (n = 224)1
Mean age (yr)	54.6 ± 10.7
Male sex	190 (84.8)
Liver cirrhosis	122 (54.5)
Diabetes mellitus	27 (12.1)
Overweight or obesitya	95 (58.6)
Hypertension	59 (26.3)
Body weight (kg)	68.8 ± 11.0
Body heighta (cm)	169.4 ± 6.4
Mean body mass indexa (kg/m2)	23.9 ± 3.4
Systolic blood pressure (mmHg)	128 ± 16
Diastolic blood pressure (mmHg)	79 ± 9
Mean artery pressure (mmHg)	95 ± 10
Past history of HBV infection	173 (77.2)
Smoking	99 (44.2)
Alcohol intake	69 (30.8)
Positive for HBeAgb	52 (26.1)
HBV-DNAc, Log10	5.32 ± 1.40
AFPd, > 400 ng/mL	110 (50.9)
Child-Pugh Score2	6 (5-8)
Blood Glucose (mmol/L)	5.88 ± 2.22
Total Bilirubin2 (mg/L)	13 (8-23)
Albumin level (g/L)	36.6 ± 6.3
International normalized ratio	1.22 ± 0.24
Alanine aminotransferase2 (U/L)	53 (34-83)
γ-glutamyl transferase2 (U/L)	113 (58-254)
Platelet count2 (× 109/L)	125 (81-183)
Triglyceridese (mmol/L)	1.02 ± 0.52
Total cholesterole (mmol/L)	4.27 ± 1.33
HDL cholesterolf (mmol/L)	0.93 ± 0.44
LDL cholesterolf (mmol/L)	2.44 ± 1.06
Creatinine2 (mg/dL)	0.9 (0.8-1.0)
Blood urea nitrogen2 (mmol/L)	4.98 (3.92-6.28)

¹Plus-minus value indicates mean ± SD;

²Median (inter-quartile range, Q1-Q3). Data were available in

^a162,

^b199,

^c57,

^d216,

^e148 and

^f132 patients. AFP: α-fetoprotein; HBV: Hepatitis B virus; HDL: High-density lipoprotein; LDL: Low-density lipoprotein.